 | |
 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.044.428 |
| Chemical and physical data | |
| Formula | C12H11I3N2O5 |
| Molar mass | 643.942 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Ioxitalamic acid (brand name Telebrix) is a pharmaceutical drug used as an iodinated contrast medium for X-ray imaging.[1][2] It is used in form of its salts, ioxitalamate sodium and ioxitalamate meglumine.[3] It was first marketed in 1970.
References
edit- ^ Wiggli U (January 1979). "[Clinical study of the tolerance for 2 iodine containing contrast media for computerized tomography of the skull]". Schweizerische Medizinische Wochenschrift. 109 (2): 51–4. PMID 370976.
- ^ El-Garawani I, Hassab El-Nabi S, El Kattan A, Sallam A, Elballat S, Abou-Ghanima S, et al. (February 2021). "The Ameliorative Role of Acacia senegal Gum against the Oxidative Stress and Genotoxicity Induced by the Radiographic Contrast Medium (Ioxitalamate) in Albino Rats". Antioxidants. 10 (2): 221. doi:10.3390/antiox10020221. PMC 7912984. PMID 33540787.
- ^ International Drug Names: Telebrix. Accessed 2021-03-31.
 | This pharmacology-related article is a stub. You can help Wikipedia by adding missing information. |
